The Bioterrorism Act

Falk, PhD,Arthur;

Publication

Article

January 2, 2004

Pharmaceutical Technology

Pharmaceutical Technology-01-02-2004

Volume28

Issue 1

The Bioterrorism Act

Author(s):

Arthur J. Falk, PhD

Two FDA final rules issued in response to the Bioterrorism Response Act of 2002 may significantly affect the supply and importation of pharmaceutical excipients.

External Link - article-81478.pdf

Articles in this issue

Coprocessed Excipients for Solid Dosage Forms

Manufacturing Execution Systems

State-of-the-Art Packaging Machines

January 2004

Medicare Bill Contains Significant Changes for Drug Manufacturers

The Bioterrorism Act

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

The Bioterrorism Act

Newsletter